| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 97530451 | FILING DATE | 08/02/2022 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | WATSON, JULIE A |
L.O. ASSIGNED | 109 |
PUB INFORMATION |
|||
| RUN DATE | 10/19/2023 | ||
| PUB DATE | 03/21/2023 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 10/17/2023 | ||
| LITERAL MARK ELEMENT | ZEPBOUND | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | ZEPBOUND |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Eli Lilly and Company |
| ADDRESS | Lilly Corporate Center Indianapolis, IN 46285 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Indiana |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) blue and green is/are claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of the wording "ZEPBOUND" in stylized font, "ZEP" in blue and "BOUND" in green with a cutout of an arrowhead on the left side of the letter "B" and three green arrowheads after the word. |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/19/2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 020 |
| 10/17/2023 | EX1G | S | SOU EXTENSION 1 GRANTED | 019 |
| 10/17/2023 | EXT1 | S | SOU EXTENSION 1 FILED | 018 |
| 10/17/2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | 017 |
| 05/16/2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 016 |
| 03/21/2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 015 |
| 03/21/2023 | PUBO | A | PUBLISHED FOR OPPOSITION | 014 |
| 03/01/2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 013 |
| 02/15/2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 012 |
| 02/15/2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 011 |
| 02/15/2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 010 |
| 02/15/2023 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 009 |
| 02/15/2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 008 |
| 02/01/2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 02/01/2023 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 02/01/2023 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 02/01/2023 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 08/24/2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 08/23/2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 002 |
| 08/05/2022 | NWAP | I | NEW APPLICATION ENTERED | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Bruce W. Longbottom |
| CORRESPONDENCE ADDRESS | Bruce W. Longbottom ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS,IN 46285 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Eli Lilly and Company |
| ADDRESS | Lilly Corporate Center Indianapolis, IN 46285 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Indiana |